Following eyonis® LCS' FDA 510 (k) clearance announced on February 9, 2026, Median has activated a phased U.S. launch strategy designed for disciplined national expansion. The Company has conducted ...
The US Food and Drug Administration (FDA) has granted marketing clearance to Eyonis LCS, an artificial intelligence-powered ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. As part of its bid to transform the future of cancer screening and seize control of ...
SPRINGFIELD, Mo. (KY3) - Mercy is offering a new, revolutionary cancer screening that can detect around fifty types of cancer even earlier with a simple blood test. It’s called Multi-Cancer Early ...
Since its peak in 1991, the cancer death rate has dropped 34%, averting an estimated 4.5 million deaths due, in part, to earlier detection of the most common types of cancer. Screening tests are ...
Carter-Bawa is a behavioral scientist and director of the Cancer Prevention Precision Control Institute at the Hackensack Meridian Center for Discovery & Innovation. For years, federal policymakers ...
Colorectal cancer is the second-leading cause of cancer related death in the U.S., with nearly 53,000 1 fatalities expected in 2025. While the burden of this disease is significant, advancements in ...
Add Yahoo as a preferred source to see more of our stories on Google. Cervical cancer screening is about to get a lot more convenient. That’s because the latest cervical cancer screening guidelines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results